Showing 1 - 4 of 4 Viral Diseases
A Phase 2/3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Hospitalized Adults With COVID-19

Status: Enrolling

Investigator: Daniela Moran

Study Coordinator:

Phone:

Treatment ... Read more >

Single dose rATG for rejection

Status: Enrolling

Investigator: Ahmed Gaber

Study Coordinator: Jennifer Spenser

Phone: 281.253.3988

Rabbit antithymocyte globulin (rATG) is approved for the treatment of acute rejection following kidney transplantation and is routinely administered as a series of 5-7 consecutive daily doses via central intravenous catheter. This prolonged cour ... Read more >

The COVID-19 and Cancer Consortium CCC19 Registry

Status: Open Not Enrolling

Investigator: Eric Bernicker

Study Coordinator:

Phone:

Cancer patients have an almost unique risk profile in this pandemic. Many patients, especially those actively on treatment, have high levels of contact with the healthcare system. Many if not all cancer patients are immunocompromised, through th ... Read more >

The Safety of EIDD-2801 and Its Effect on Viral Shedding of SARS-CoV-2

Status: Enrolling

Investigator: Daniela Moran

Study Coordinator:

Phone:

Treatment ... Read more >